glp-1 receptor agonist nausea diarrhea management Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine GLP-1 receptor agonists for individualized
Description
Among the 235 participants in the semaglutide group who completed the treatment period, 89.8% were receiving the full 2.4-mg dose at the last treatment visit
2020 [citato 1 gennaio 7d.C.];14(4):28992
GLP-1 receptors are found throughout the body, including in the gut, brain, and pancreas
Hong Y, Feng J, Dou Z, Sun X, Hu Y, Chen Z, et al
In our large, nationwide cohort study with a median follow-up of 8 years, we observed no increase in pancreatic cancer risk with GLP-1 RA use compared to other antidiabetic drug users
2019;42(9):e1412
